Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis falls 4% on MS drug concerns
Novartis falls 4% on MS drug concerns
Novartis falls 4% on MS drug concerns
Submitted by
admin
on January 20, 2012 - 12:19pm
Source:
Marketwatch
News Tags:
MS
Novartis
Gilenya
multiple sclerosis
Headline:
Novartis falls 4% on MS drug concerns
Do Not Allow Advertisers to Use My Personal information
